Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610461 · ClinicalTrials.gov registry record · NA
High-flow Nasal Oxygen Therapy for Advanced Endoscopy in High-risk Patients.
A NA study of Hypoxemia During Surgery, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06610461 is a NA study of Hypoxemia During Surgery that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 180 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06610461, a NA study of Hypoxemia During Surgery, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Anesthesia is crucial during upper GI endoscopy in order to improve the procedural conditions for the interventionist, increase the quality of examination and alleviate patient discomfort. However, sedation during endoscopy carries a serious risk of blood oxygen desaturation. This study aims to investigate the hypothesis if the application of high-flow nasal oxygen (HFNO) during high-risk gastroscopy reduces the risk of blood oxygen levels to drop below a defined threshold. Enrolled patients will be randomly assigned to either the control group, receiving standard care during endoscopy, or the intervention group, receiving HFNO therapy during the procedure. Throughout the intervention, vital parameters will be recorded. Care providers will be asked to answer a questionnaire that specifically evaluates the effect of HFNO on patient safety and the procedure.
Conditions Studied
Interventions
- DEVICE HFNO-Treatment
Study Locations (1)
Massachusetts
- Anesthesia, Critical Care and Pain Medicine Department at Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-09-25 |
| Est. Completion | 2025-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06610461
The ClinicalTrials.gov registry entry for NCT06610461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypoxemia During Surgery appearing as the primary indexed condition, and to 1 intervention - of which HFNO-Treatment is the first listed.
NCT06610461 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06610461 about?
NCT06610461 is a clinical study titled "High-flow Nasal Oxygen Therapy for Advanced Endoscopy in High-risk Patients.". Anesthesia is crucial during upper GI endoscopy in order to improve the procedural conditions for the interventionist, increase the quality of examination and alleviate patient discomfort. However, sedation during endoscopy carries a serious risk of blood oxygen desaturation. This study aims to inv...
What is the current status of trial NCT06610461?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2024-09-25. Estimated completion is 2025-09-12.
What conditions does trial NCT06610461 study?
This clinical trial studies the following conditions: Hypoxemia During Surgery.
What interventions are being tested in trial NCT06610461?
The interventions under investigation include: HFNO-Treatment (DEVICE).
Who is sponsoring clinical trial NCT06610461?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06610461 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.